Profil
Dr. Dolores J.
Schendel is a Chief Scientific Officer at MediGene AG and a Chief Executive Officer at Medigene, Inc. Dr. Schendel was previously employed as a Managing Director by Medigene Immunotherapies GmbH, a Member-Scientific Review Board by Deutsche Forschungsgemeinschaft, a Member-Scientific Review Board by European Research Council, a Member-Scientific Review Board by German Cancer Aid, and a Professor by Ludwig-Maximilians-Universität München.
She also served on the board at Institute of Molecular Immunology.
She received her doctorate degree from the University of Wisconsin.
Aktive Positionen von Dolores Schendel
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIGENE AG | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Dolores Schendel
| Unternehmen | Position | Ende |
|---|---|---|
Institute of Molecular Immunology | Direktor/Vorstandsmitglied | 01.01.2013 |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Corporate Officer/Principal | - |
German Cancer Aid | Corporate Officer/Principal | - |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Vorstandsvorsitzender | - |
Ausbildung von Dolores Schendel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
MediGene AG
MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Miscellaneous |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Molecular Immunology | |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Health Technology |
German Cancer Aid |
















